ALC - Alcon Profit before interest, taxes and amortization

Graphic logo of alcon.com (ALC)

Alcon Inc. is increasing production sustainability and the accessibility of ophthalmology, which is confirmed by the current EBITDA_Co level. The value 2454.50 serves as the current parameter value. However, dependence on the number of surgeries and strict regulatory oversight create certain risks. For expansion, the company relies on the targeted acquisition of startups, integrating advanced laser developments into its ecosystem.

Operating profit EBITDA: Alcon Vision (ALC) for 11/23/2025 - 11/10/2026

Alcon (ALC) - metric breakdowns and financial figures

- market value and analyst target forecast:
Market Price Alcon Corp|ALC - Analyst Consensus Forecast
- market capitalization statistics:
Market Value Alcon|ALC - Total Company Value
- book capitalization data:
Net Assets per Share Alcon|ALC - Book Capitalization|Market Capitalization to Book Value Ratio alcon.com|ALC - Aggregate Company Assets
- debt level and financial liquidity data:
Debt to Equity Alcon Inc.|ALC - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Alcon Inc|ALC - Company Debts|Debts to Book Value Alcon|ALC - Company Long-Term Debt|Company Short-Term Indebtedness Alcon|Intermediate Coverage Ratio alcon.com
- company profitability and valuation multiples indicators:
ALC - Net Profit|Company Profit Forecast Alcon Inc.|ALC - Price to Earnings Ratio|Price to Future Earnings Ratio alcon.com|ALC - PEG Multiple|Enterprise Value to EBITDA Ratio Alcon|ALC - Operating profit before deduction of amortization|Net earnings per share for the last four quarters Alcon|ALC - Net earnings per share (EPS TTM)|Quarterly EPS earnings growth alcon.com|ALC - Earnings per share growth in current year|Net earnings per share growth forecast for next year Alcon Inc.
Analysis of all company metrics:Alcon Inc.
Manufactured products of Alcon Vision

Alcon Inc. is optimizing costs by outsourcing instrument production and clinical trials to third-party contractors. Current cash operating profit reflects the actual cash flow from these activities, excluding non-cash depreciation and amortization charges. By analyzing the trend of this cash operating profit, an investor assesses the efficiency of capital management. Growth in this metric confirms the scalability of the business, although sharp spikes require verification for hidden borrowing.

Competitors of Alcon Inc. (ALC)

Bausch Health (BLCO) - Profit before interest, taxes and amortization|Glaukos Corporation - Operating profit EBITDA|Profit before interest, taxes and amortization apellis.com|Belite Bio Corp (BLTE) - Profit before payment of interest, taxes and amortization|OCUL - Operating income before deduction of amortization|HROW (Harrow Health) - Operating profit EBITDA|Operating profit EBITDA Viridian Corp|Profit before payment of interest, taxes and amortization LENZ Therapeutics, Inc. (LENZ)|Profit before payment of interest, taxes and amortization OCS (Oculis Holding AG)|Operating profit EBITDA EYPT (EyePoint Pharmaceuticals, Inc.)|KOD - Operating profit before deduction of amortization|ALDX - Profit before payment of interest, taxes and amortization|Profit before interest, taxes and amortization KALA BIO, Inc.|opusgtx.com (IRD) - Profit before payment of interest, taxes and amortization|Operating profit before amortization OKYO|Operating profit before deduction of amortization ADVM|OTLK: Income before deduction of interest, taxes and amortization|Operating profit EBITDA CLSD|Operating income before deduction of amortization novabay.com|Profit before payment of interest, taxes and amortization Kiora Pharmaceuticals, Inc. KPRX|ALIM: Operating profit before amortization|Eyenovia Corp - Operating profit EBITDA|Guardion Health Sciences, Inc. (GHSI) - Operating profit before deduction of amortization|OCUP (Ocuphire) - Operating profit before deduction of amortization|OPT - Operating income before deduction of amortization